Mark B. Langdon

Practice Areas

MARK B. LANGDON is a nationally-recognized thought leader and counselor who practices in the Healthcare group out of the firm’s Washington, D.C., office. He routinely speaks and writes about cutting-edge healthcare issues facing life sciences companies.

Mr. Langdon has represented a diverse array of life sciences and healthcare industry clients on numerous regulatory, enforcement, compliance, fraud and abuse, transactional, and reimbursement matters. His clients have primarily included pharmaceutical and device manufacturers, biotech companies, hospitals, physician practices, clinical laboratories, durable medical equipment companies and imaging companies.

Mr. Langdon regularly advises healthcare companies regarding regulatory, enforcement, and compliance issues. He has particular knowledge on the federal anti-kickback statute, the federal physician “Stark” Law and the False Claims Act, and routinely counsels clients on the implications of entering into certain transactions under those laws, and on how to structure such arrangements in a compliant fashion.

Mr. Langdon also has extensive experience defending clients in criminal and civil healthcare fraud investigations. In particular, he has been involved in representing numerous life sciences companies, including medical device, pharmaceutical and dialysis companies, in several leading nationwide healthcare fraud investigations conducted by the U.S. Department of Justice and the Office of Inspector General of the federal Department of Health and Human Services. He has negotiated corporate integrity agreements and settlement agreements with the Office of Inspector General, U.S. Attorneys’ offices, and State Medicaid Fraud Control Units, on behalf of device and pharmaceutical clients. He has recently defended a pharmaceutical manufacturer accused of violating the False Claims Act and the federal Anti-Kickback Statute relating to various market share rebates and other discounting programs with customers.

Mr. Langdon also regularly counsels life sciences companies on the development and implementation of corporate compliance programs, including drafting and amending policies and procedures, conducting corporate compliance training, and spearheading internal audits and investigations.